High-grade serous ovarian cancer (HGSOC) is a challenging malignancy characterized by complex interactions between tumor cells and the surrounding microenvironment. Understanding the immune landscape of HGSOC, particularly the role of the extracellular m
Prostate cancer remains a challenge due to its incidence and radical prostatectomy continues to be a major treatment option for men with potentially curable disease who have a life expectancy over a decade. This article will address the common problem of positive surgical margins and the impact of...
4. A phase 3 single-arm study of UGN-102 for treatment of low grade intermediate risk non-muscle-invasive bladder cancer (ENVISION). ClinicalTrials.gov. Last updated July 12, 2024. Accessed August 14, 2024. https://clinicaltrials.gov/study/NCT05243550...
Patients with bladder cancer had significant higher complication rates. Survival rate for one year was 65%. In survival analysis the only significant parameter was having bladder cancer rather than other malignancies (P=0.046). Conclusions: Treatment decisions due to life expectancy may be a key in...
(Figure 3). These results suggest that such approaches may be most effective if applied early in treatment, particularly in patients likely to have a robust immunity, such as the patients who have not yet received any chemotherapy or radiation therapy. In fact, cancer vaccines often need more ...